Skip to content
Medical Health Aged Care

CGFNS International and The DAISY Foundation Honor Outstanding International Nurse Recruiters

CGFNS International 3 mins read

PHILADELPHIA, PA / ACCESSWIRE / March 11, 2024 / CGFNS International and The DAISY FoundationTM this evening honored two nurses for their contributions to ethical international recruitment practices with the first-ever CGFNS DAISY Award for Outstanding International Nurse Recruiter. The presentation was made at a ceremony in New York City.

CGFNS International and The DAISY Foundation
CGFNS International and The DAISY Foundation

Sinead Carbery, President of International Staffing Solutions for AMN Healthcare, and Christy Craft, a quality improvement nurse manager at Health Carousel, were selected as honorees from more than 140 submitted nominations.

Both honorees are registered nurses working at health professional recruitment firms and were recognized for their commitment to helping foreign-educated nurses cope with the challenges they face as they navigate their way to employment in the U.S. health system.

Carbery, herself an immigrant nurse from Ireland, has helped thousands of other migrating nurses over her nearly three decades in international recruitment. She is noted for her commitment to ethical recruitment practices and her compassion for migrating nurses and their families during their journey.

Craft leads a team whose effort resulted in more than 500 nurse assignment placements in 2023 alone. Under her guidance, the team also runs transition-to-practice and clinical residency programs that prepare migrating nurses for their duties as RNs in the U.S.

The CGFNS DAISY Award for Outstanding International Nurse Recruiter is open to individual nurses actively engaged, either directly or indirectly, in international nurse recruitment efforts. With a focus on "nurses helping nurses," the award honors those who have made an extraordinary impact on the lives of nurse migrants through their compassion, empathy, and embodying the principles of the recruitment code from the CGFNS Alliance for Ethical International Recruitment Practices.

The award was presented by CGFNS International President and CEO Dr. Peter Preziosi and Dr. Deb Zimmermann, CEO of The DAISY Foundation.

About CGFNS International, Inc.
Founded in 1977 and based in Philadelphia, CGFNS International is an immigration-neutral not-for-profit organization proudly serving as the world's largest credentials evaluation organization for the nursing and allied health professions. CGFNS International is an NGO in Consultative Status with the United Nations Economic and Social Council (ECOSOC) and is a member of the Conference of NGOs in Consultative Relationship with the United Nations (CoNGO).

About The DAISY Foundation
The DAISY Foundation is a not-for-profit organization, established in memory of J. Patrick Barnes, by members of his family. Patrick died at the age of 33 in late 1999 from complications of Idiopathic Thrombocytopenic Purpura (ITP), a little-known but not uncommon auto-immune disease. (DAISY is an acronym for Diseases Attacking the Immune System.) The care Patrick and his family received from Nurses while he was ill inspired the creation of The DAISY Award® for Extraordinary Nurses, an evidenced-based means of providing Nurse recognition and thanking Nurses for making a profound difference in the lives of their patients and patient families. In addition to the DAISY Award® for Extraordinary Nurses, the Foundation expresses gratitude to the nursing profession internationally in over 6,500 healthcare facilities and schools of nursing with recognition programs for nurses wherever they practice, in whatever role they serve, and throughout their careers - from nursing student through lifetime achievement, and through several lines of research grant and evidence-based practice projects funding. More information is available at https://DAISYfoundation.org.

Contact Information

David St. John
dstjohn@cgfns.org

SOURCE: CGFNS International

.

View the original press release on newswire.com.

More from this category

  • Medical Health Aged Care
  • 13/09/2024
  • 12:40
Zenas BioPharma

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price of $17.00 per share. All of the shares are being offered by Zenas. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $225.0 million. Zenas’ common stock is expected to begin trading…

  • Medical Health Aged Care
  • 13/09/2024
  • 12:31
Dementia Australia

New report reinforces dementia as chronic disease of 21st century

Updates to the Dementia in Australia report, released today by the Australian Institute of Health and Welfare (AIHW), reinforce that dementia is an urgent public health issue. Dementia is the second leading cause of death in Australia, the leading cause of death of women, the second leading cause of disease burden overall, and the leading cause of burden for people aged 65 and over. Dementia Australia CEO Professor Tanya Buchanan saidthe report highlights the enormity and impact of dementia in Australia as the chronic disease of the 21st century. “Despite the growing number of Australians diagnosed with dementia – there…

  • Medical Health Aged Care, Science
  • 13/09/2024
  • 11:08
La Trobe University

Centre to play key role in global AI medical research

Artificial intelligence promises to unlock new cures for cancer and other diseases by revolutionising the speed, cost and availability of personally designed drugs and enabling these to be tested on “digital twins" before being given to patients. AI will enable broad-spectrum like chemotherapy to be replaced by these more personalised, better targeted treatments. Scientists at La Trobe University's new Australian Centre for Artificial Intelligence in Medical Innovation (ACAMI), launched today, will also apply AI techniques to mRNA therapy development to enable faster design of more precise and effective treatments. Vice-Chancellor Professor Theo Farrell said ACAMI would sit within La Trobe’s…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.